Trial intelligence / Profile preview

Effectiveness of memantine in improvement of cognitive deficits in specific learning disorder

IRCT2015102124633N1Phase 2Completed

Sponsor
Arak University of Medical Sciences
Start
Oct 2014
Modality
Small Molecules
Countries
1
01

Overview

Phase 2 trial of memantine in learning disorder, sponsored by Arak University of Medical Sciences. Started Oct 2014; status: completed.

02

Drugs

memantine
03

Conditions

learning disorder

Beyond the preview

Go deeper on IRCT2015102124633N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT2015102124633N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call